Kura Oncology (KURA) EBIT (2010 - 2026)
Kura Oncology's EBIT was -$73.01 million in Q2 2026, compared with -$72.67 million a year earlier.
Powered by 
Analysis
Kura Oncology (KURA) EBIT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kura Oncology's EBIT was -$306.13 million through Jun 30, 2026; for FY2025, it came in at -$303.63 million.
- In earlier years, EBIT was -$193.2 million in FY2024, -$165.8 million in FY2023 and -$139.87 million in FY2022.
- Quarterly EBIT has moved between -$80.58 million (Q4 2025) and -$16.8 million (Q4 2024) over five years.
- Per Business Quant data, KURA's EBIT in the three quarters before Q2 2026 was -$78.82 million (Q1 2026), -$80.58 million (Q4 2025) and -$73.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,167.17 Bn | 1,135.76 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 633.70 Bn | 552.23 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.94 Bn | 477.06 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 378.10 Bn | 332.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.72 Bn | 267.71 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 266.46 Bn | 240.15 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 241.07 Bn | 196.47 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.22 Bn | 168.41 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Kura Oncology | 876.11 Mn | -1.44 Bn | 20.63 Mn | -73.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -73.01 Mn |
| Mar 31, 2026 | -78.82 Mn |
| Dec 31, 2025 | -80.58 Mn |
| Sep 30, 2025 | -73.72 Mn |
| Jun 30, 2025 | -72.67 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2024 | -16.80 Mn |
| Sep 30, 2024 | -53.99 Mn |
| Jun 30, 2024 | -50.43 Mn |
| Mar 31, 2024 | -49.13 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
API Access
Kura Oncology EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();